Skip to Main Content

1,532

Views

1

CrossRef citations to date

0

Altmetric

Original Research Article

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement

Bérengère Macabeoa Aix-Marseille Université, Marseille, France;b Pierre Fabre Group, Paris, FranceCorrespondence[email protected]
View further author information

,

Liam Wilsonc Health Economics and Market Access, Amaris Consulting, Shanghai, ChinaView further author information

,

Jianwei Xuand Health Economic Research Institute, Sun Yat-Sen University, Guangzhou, ChinaView further author information

,

Ruichen Guoe Institute of Clinical Pharmacology, Qilu Hospital of Shandong University, Jinan, ChinaView further author information

,

Petar Atanasovf Health Economics and Market Access, Amaris Consulting, Barcelona, SpainView further author information

,

Linda Zhengg Pierre Fabre Group, Shanghai, ChinaView further author information

,

Clement Françoisa Aix-Marseille Université, Marseille, France;h Putnam Associates, Paris, FranceView further author information

&

Philippe Laraméea Aix-Marseille Université, Marseille, France;b Pierre Fabre Group, Paris, FranceView further author information